Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Rev Esp Quimioter ; 34(5): 491-495, 2021 Oct.
Artículo en Español | MEDLINE | ID: mdl-34266230

RESUMEN

OBJECTIVE: Currently the prevalence of pneumococcal coinfection in patients with COVID-19 is unknown. In this work we present its clinical characteristics, evolution and treatment. METHODS: Retrospective data collection from August to October 2020 in two hospitals in the Murcia region. RESULTS: Eighteen patients had COVID-19 diagnosed by PCR and pneumococcal infection confirmed by antigenuria, which represented a prevalence of 2%. A total of 88% had radiological alterations upon admission (two patients had an X-ray within normality) and 29% had elevated procalcitonin. Mortality in our series was 12%. CONCLUSIONS: It could be reasonable to consider the start of antimicrobial therapy in those cases in which there is a moderate or high suspicion of bacterial coinfection, being essential the early suspension of antibiotic treatment if it is not confirmed.


Asunto(s)
COVID-19 , Coinfección , Coinfección/tratamiento farmacológico , Humanos , Estudios Retrospectivos , SARS-CoV-2 , Streptococcus pneumoniae
2.
Rev Esp Quimioter ; 33(6): 430-435, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33246358

RESUMEN

OBJECTIVE: Methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum ß-lactamase-producing Enterobacterales (ESBL-E) may complicate the treatment of diabetic foot infections (DFIs). The aim of this study was to determine the risk factors for these pathogens in DFIs. METHODS: This was a prospective observational study of 167 consecutive adult patients with DFIs. The diagnosis and severity of DFIs were based on the Infectious Disease Society of America (IDSA) classification system. Multivariate analyses were performed in order to identify risk factors for MRSA and ESBL-E infections. RESULTS: S. aureus was the most isolated pathogen (n=82, 37.9 %) followed by Escherichia coli (n= 40, 18.5%). MRSA accounted for 57.3% of all S. aureus and 70% of Klebsiella pneumoniae and 25% of E. coli were ESBL producers, respectively. Deep ulcer [OR 8,563; 95% CI (1,068-4,727)], previous use of fluoroquinolones [OR 2,78; 95% CI (1,156-6,685)] and peripheral vasculopathy [OR 2,47; 95% CI (1.068-4.727)] were the independent predictors for MRSA infections; and osteomyelitis [OR 6,351; 95% CI (1,609-25,068)] and previous use of cephalosporins [OR 5,824; 95% CI (1,517-22,361)] for ESBL-E infections. CONCLUSIONS: MRSA and ESBL-E have adquired a great clinical relevance in DFIs. The availability of their risk factors is very convenient to choose the empirical treatment in severe forms.


Asunto(s)
Diabetes Mellitus , Pie Diabético , Staphylococcus aureus Resistente a Meticilina , Adulto , Pie Diabético/microbiología , Escherichia coli , Hospitales , Humanos , Factores de Riesgo , beta-Lactamasas
4.
Int J Antimicrob Agents ; 52(5): 577-585, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29969692

RESUMEN

PURPOSE: There are few data in the literature regarding sepsis or septic shock due to extended-spectrum ß-lactamases (ESBL)-producing Enterobacteriaceae (E). The aim of this study was to assess predictors of outcome in septic patients with bloodstream infection (BSI) caused by ESBL-E. METHODS: Patients with severe sepsis or septic shock and BSI due to ESBL-E were selected from the INCREMENT database. The primary endpoint of the study was the evaluation of predictors of outcome after 30 days from development of severe sepsis or septic shock due to ESBL-E infection. Three cohorts were created for analysis: global, empirical-therapy and targeted-therapy cohorts. RESULTS: 367 septic patients were analysed. Overall mortality was 43.9% at 30 days. Escherichia coli (62.4%) and Klebsiella pneumoniae (27.2%) were the most frequent isolates. ß-lactam/ß-lactamase inhibitor (BLBLI) combinations were the most empirically used drug (43.6%), followed by carbapenems (29.4%). Empirical therapy was active in vitro in 249 (67.8%) patients, and escalation of antibiotic therapy was reported in 287 (78.2%) patients. Cox regression analysis showed that age, Charlson Comorbidity Index, McCabe classification, Pitt bacteremia score, abdominal source of infection and escalation of antibiotic therapy were independently associated with 30-day mortality. No differences in survival were reported in patients treated with BLBLI combinations or carbapenems in empirical or definitive therapy. CONCLUSIONS: BSI due to ESBL-E in patients who developed severe sepsis or septic shock was associated with high 30-day mortality. Comorbidities, severity scores, source of infection and antibiotic therapy escalation were important determinants of unfavorable outcome.


Asunto(s)
Técnicas de Apoyo para la Decisión , Infecciones por Enterobacteriaceae/diagnóstico , Infecciones por Enterobacteriaceae/mortalidad , Enterobacteriaceae/enzimología , Sepsis/diagnóstico , Sepsis/mortalidad , beta-Lactamasas/metabolismo , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Quimioterapia Combinada , Enterobacteriaceae/aislamiento & purificación , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Infecciones por Enterobacteriaceae/microbiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Sepsis/tratamiento farmacológico , Sepsis/microbiología , Análisis de Supervivencia , Resultado del Tratamiento , Inhibidores de beta-Lactamasas/uso terapéutico , beta-Lactamas/uso terapéutico
5.
Rev Esp Quimioter ; 30(5): 350-354, 2017 Oct.
Artículo en Español | MEDLINE | ID: mdl-28737025

RESUMEN

OBJECTIVE: The aim of the study was to analyze the impact of steroid treatment in patients with community acquired pneumonia (CAP), both in length of stay and economical cost of admission at a clinical university hospital. METHODS: Prospective study of admitted patients with the diagnosis of CAP, both in Internal Medicine and Infectious diseases department. The study was conducted from January to march 2015; patients receiving steroids from diagnosis to end of antibiotic treatment were classified as group I; otherwise, they were considered in group II. Administration of steroids was done according to the criteria of the responsible. Cost was stablished according to CAP Diagnostic Related Group (DRG). RESULTS: Prevalence of patients younger than 65 year-old was higher in group I (p<0.05). In bivariate analyses, mean admission time was lower in group I (5.37 vs 8.88 days) (p<0.0005) and also economical cost (2,361 euros vs 3,907 euros) (p<0.0005). In multivariate analysis, factors independently associated to higher cost (>3,520 euros) were COPD (OR=2.602; 95% CI 1.074-6.305) and group II (patients with no steroids) (OR=6.2; p=0,007). CONCLUSIONS: No administration of steroids in patients with CAP was associated, together with COPD, with higher economical cost (evaluated by DRG/length of stay).


Asunto(s)
Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Infecciones Comunitarias Adquiridas/economía , Neumonía/tratamiento farmacológico , Neumonía/economía , Esteroides/economía , Esteroides/uso terapéutico , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Protocolos Clínicos , Infecciones Comunitarias Adquiridas/epidemiología , Costos y Análisis de Costo , Femenino , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Neumonía/epidemiología , Prevalencia , Estudios Prospectivos , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Enfermedad Pulmonar Obstructiva Crónica/economía , España/epidemiología
6.
Rev Esp Quimioter ; 30(1): 19-27, 2017 Feb.
Artículo en Español | MEDLINE | ID: mdl-27898208

RESUMEN

OBJECTIVE: Outpatient parenteral antimicrobial therapy (OPAT) programs are a good assistance option in a wide variety of infectious diseases. Our aim was to design and implement an OPAT program in the area of influence of a second-level hospital, with no Home Hospitalization Service available, being necessary close collaboration between hospitalization and Primary Care teams, describe our cohort, analyse the antimicrobial treatment indicated and evaluate the prognostic and risk factors associated with readmission and mortality. METHODS: Prospective study cohorts of patients admitted to the OPAT programme, from 1 January 2012 to 31 May 2015. RESULTS: During the period of study a total of 98 episodes were recorded. The average age of the cohort was 66 years. The most frequent comorbidity was immunosuppression (33.67 %), with an overall average of Charlson index of 5.21 ± 3.09. The most common source of infection was respiratory (33.67 %). Microbiological isolation was achieved in fifty-eight patients (59.18 %) being Escherichia coli the most frequently isolated (25%). The average number of days of antibiotics administration at home was 10.42 ± 6.02 (SD), being carbapenems (43.48%) the more administered. Eighty-six patients (87.75%) completed the treatment successfully. Thirty-two patients (32.65%) were readmitted within 30 days after being discharged and seven patients (7.14%) died. A statistically significant association was only found in the readmission with variables: elderly patients (p=0.03), being carriers of Porth-a-Cath (p=0.04) and treatment termination related with infection (p<0.05). CONCLUSIONS: This is the first programme of OPAT administration not dependent on Home Hospitalization Service in Spain, which could allow to optimize the hospital and primary care resources available. Nevertheless this pilot study results are poor in terms of optimization of antibiotics choice, transition to oral administration, de-escalation and duration.


Asunto(s)
Atención Ambulatoria/organización & administración , Antiinfecciosos/administración & dosificación , Antiinfecciosos/uso terapéutico , Infecciones/tratamiento farmacológico , Atención Primaria de Salud/organización & administración , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Antiinfecciosos/efectos adversos , Niño , Estudios de Cohortes , Femenino , Hospitales , Humanos , Terapia de Inmunosupresión , Infecciones/microbiología , Infecciones/mortalidad , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Readmisión del Paciente/estadística & datos numéricos , Proyectos Piloto , Pronóstico , Estudios Prospectivos , España , Adulto Joven
10.
Rev Esp Quimioter ; 25(3): 199-205, 2012 Sep.
Artículo en Español | MEDLINE | ID: mdl-22987266

RESUMEN

INTRODUCTION: Coagulase-negative staphylococci (CNS) are the most frequent isolated microorganism in blood cultures; mortality has been associated to severity and to adequacy of empirical treatment but the relevance of the latter is not clearly recognised. The aims of the study were to analyze clinical and microbiological factors related to mortality in patients with CNS bacteraemia and the influence of empirical treatment in prognosis. PATIENTS AND METHODS: A prospective cohort study of patients with CNS bacteraemia was performed (January to June 2010) at a university-affiliated hospital; a determination of clinical significance was made and true bacteraemia was defined according to CDC criteria. We analysed epidemiological, clinical and microbiological variables related to mortality. RESULTS: A total of 269 cases were included (97 were considered true bacteraemia); 92% survived and mortality was 8% (1.6% CNS bacteraemia related mortality). Staphylococcus epidermidis was the most frequent isolated species; 93 patients were included in the related mortality study of patients with true bacteraemia. Factors associated to mortality in the bivariate analysis (p<0.05) were: Winton score I-III, presence of pacemakers, sepsis or infective endocarditis and persistent bacteraemia. Adequate empirical treatment was not associated to survival. CONCLUSIONS: Severity at onset, the development of septic complications and having a pacemaker are associated to mortality in patients with CNS bacteraemia; in our cohort, inadequate empirical treatment is not related to mortality.


Asunto(s)
Antibacterianos/uso terapéutico , Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/microbiología , Anciano , Bacteriemia/mortalidad , Coagulasa , Estudios de Cohortes , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/microbiología , Infección Hospitalaria/mortalidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Sepsis/tratamiento farmacológico , Sepsis/microbiología , Sepsis/mortalidad , Infecciones Estafilocócicas/mortalidad , Staphylococcus/efectos de los fármacos
11.
Actas Urol Esp ; 36(5): 302-5, 2012 May.
Artículo en Español | MEDLINE | ID: mdl-22398256

RESUMEN

OBJECTIVE: To evaluate the effect of body mass index (BMI) on PSA in northeast Mexican patients included in prostate cancer (Pca) early detection screening campaigns offered by our institution. MATERIAL AND METHODS: One hundred and ninety seven patients came voluntarily to our Pca early detection screening campaigns. EXCLUSION CRITERIA: PSA >10 ng/dl, patients on 5-α Reductase inhibitors or hormonal replacement. Overweight and obesity were considered when BMI was between 25-29.9 and ≥30 kg/m(2) respectively. Simple linear and multiple regression were used in the statistical analysis. Mean and standard deviation were utilized to evaluate spread and normal distribution. P values <0.05 were considered statistically significant. RESULTS: One hundred and fifty two patients were included in this study. Forty four percent (83) and 30.3%(46) presented with overweight and obesity, respectively. Mean BMI was 28.16 kg/m(2) (SD 1.77). A statistically significant negative effect of BMI on PSA was observed in the linear regression. This effect persisted when adjusted for age in the multiple regression model. A decrease of 0.085 ng/dl for every unit of BMI (p <0.001) was observed in the simple linear regression. This value was 0.07 in the multiple regression (p=0.006) CONCLUSIONS: A higher negative effect of BMI on PSA was found in comparison to published literature. A higher proportion of patients with BMI >25 kg/m(2) than the national mean was observed. A multicentric national study is needed in order to challenge these results.


Asunto(s)
Índice de Masa Corporal , Antígeno Prostático Específico/sangre , Humanos , Masculino , México , Persona de Mediana Edad , Estudios Prospectivos
12.
Antimicrob Agents Chemother ; 55(9): 4308-10, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21690277

RESUMEN

The aim of this study is to describe our experience with linezolid plus rifampin as a salvage therapy in prosthetic joint infections (PJIs) when other antibiotic regimens failed or were not tolerated. A total of 161 patients with a documented prosthetic joint infection were diagnosed with a PJI and prospectively followed up from January 2000 to April 2007. Clinical characteristics, inflammatory markers, microbiological and radiological data, and antibiotic treatment were recorded. After a 2-year follow-up, patients were classified as cured when the prosthesis was not removed, symptoms of infection disappeared, and inflammatory parameters were within the normal range. Any other outcome was considered a failure. The mean age of the entire cohort (n = 161) was 67 years. Ninety-five episodes were on a knee prosthesis (59%), and 66 were on a hip prosthesis (41%). A total of 49 patients received linezolid plus rifampin: 45 due to failure of the previous antibiotic regimen and 4 due to an adverse event associated with the prior antibiotics. In no case was the implant removed. The mean (standard deviation) duration of treatment was 80.2 (29.7) days. The success rate after 24 months of follow-up was 69.4% (34/49 patients). Three patients developed thrombocytopenia and 3 developed anemia; however, it was not necessary to stop linezolid. Linezolid plus rifampin is an alternative salvage therapy when the implant is not removed.


Asunto(s)
Acetamidas/uso terapéutico , Antiinfecciosos/uso terapéutico , Oxazolidinonas/uso terapéutico , Infecciones Relacionadas con Prótesis/tratamiento farmacológico , Rifampin/uso terapéutico , Terapia Recuperativa/métodos , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Estudios de Seguimiento , Prótesis de Cadera/microbiología , Humanos , Prótesis de la Rodilla/microbiología , Linezolid , Masculino , Persona de Mediana Edad
13.
Biosystems ; 58(1-3): 117-24, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11164638

RESUMEN

Discrete sequence analysis methods were applied to study spike-trains generated by the isolated neuron of the slowly adapting stretch receptor organ. Calculation of the algorithmic complexity and block entropies of digitized individual spike-train forms allowed us to distinguish different classes of neural behavior. While some spike-trains exhibited significant structure, others displayed diverse degrees of randomness. The sequences recorded during the stimulated portions of the intermittent and walk-through forms, differed considerably from their randomly shuffled surrogates. Informational and grammar complexity measures (in two, four and eight-letter alphabets), tell us things about the structure of spike-trains that are not obtained with conventional spike analysis. Comparison of the conditional entropies for the digitized signals showed that the method distinguishes between different stimulated conditions. Additionally, comparison of the different stimulated conditions with their corresponding surrogates showed that, both, conditional entropies and complexities were significantly different for the two groups. Although the original and the randomly shuffled sequences had the same distribution and average firing rate, their complexity values were different. The results obtained with both measures of sequence structure were quite consistent.


Asunto(s)
Potenciales de Acción , Neuronas/fisiología , Algoritmos , Animales , Crustáceos/fisiología , Termodinámica
14.
Salud Publica Mex ; 40(5): 408-14, 1998.
Artículo en Español | MEDLINE | ID: mdl-9842278

RESUMEN

OBJECTIVE: To evaluate malnutrition prevalence in children under five years-old in Tabasco, Mexico, during 1996, and their evolution in 1991-1996. MATERIAL AND METHODS: A cross-sectional study, including 1,256 children under five years-old in 593 communities (31 urban and 562 rural) from 17 sanitary districts. RESULTS: The weight/age indicator for malnutrition in children under five years old showed 59% of children had normal nutrition and 41% with malnutrition, distributed as follows: 26.12% slight, 12.62% moderate and 2.39% severe. In children between 1-5 years old, malnutrition prevalence was 45%. CONCLUSIONS: The number of children with malnutrition in Tabasco during the study period (1991-1996) has decreased in proportion to the increase of those with normal nutrition. Based on the health system activities, the number of health districts with critical malnutrition indicators decreased from 6 to 4.


Asunto(s)
Trastornos Nutricionales/epidemiología , Preescolar , Femenino , Humanos , Lactante , Masculino , México/epidemiología , Prevalencia , Salud Rural/estadística & datos numéricos , Salud Urbana/estadística & datos numéricos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA